Literature DB >> 1337029

Collaboration of pim-1 and bcl-2 in lymphomagenesis.

D Acton1, J Domen, H Jacobs, M Vlaar, S Korsmeyer, A Berns.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1337029     DOI： 10.1007/978-3-642-77633-5_36

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  10 in total

1.  Pim-1 kinase expression predicts radiation response in squamocellular carcinoma of head and neck and is under the control of epidermal growth factor receptor.

Authors:  Katriina Peltola; Maija Hollmen; Sanna-Mari Maula; Eeva Rainio; Raija Ristamäki; Marjaana Luukkaa; Jouko Sandholm; Maria Sundvall; Klaus Elenius; Päivi J Koskinen; Reidar Grenman; Sirpa Jalkanen
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

2.  PIM1 induces cellular senescence through phosphorylation of UHRF1 at Ser311.

Authors:  J Yang; K Liu; J Yang; B Jin; H Chen; X Zhan; Z Li; L Wang; X Shen; M Li; W Yu; Z Mao
Journal:  Oncogene       Date:  2017-04-10       Impact factor: 9.867

3.  Combination of Pim kinase inhibitors and Bcl-2 antagonists in chronic lymphocytic leukemia cells.

Authors:  Fabiola Cervantes-Gomez; Bethany Lavergne; Michael J Keating; William G Wierda; Varsha Gandhi
Journal:  Leuk Lymphoma       Date:  2015-09-28

Review 4.  Inflammation and survival pathways: chronic lymphocytic leukemia as a model system.

Authors:  Lisa S Chen; Kumudha Balakrishnan; Varsha Gandhi
Journal:  Biochem Pharmacol       Date:  2010-08-07       Impact factor: 5.858

5.  A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma.

Authors:  Ying-Wei Lin; Zanna M Beharry; Elizabeth G Hill; Jin H Song; Wenxue Wang; Zuping Xia; Zhenhua Zhang; Peter D Aplan; Jon C Aster; Charles D Smith; Andrew S Kraft
Journal:  Blood       Date:  2009-11-23       Impact factor: 22.113

6.  Moloney murine leukemia virus-induced lymphomas in p53-deficient mice: overlapping pathways in tumor development?

Authors:  E W Baxter; K Blyth; L A Donehower; E R Cameron; D E Onions; J C Neil
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

7.  Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion.

Authors:  Niina M Santio; Riitta L Vahakoski; Eeva-Marja Rainio; Jouko A Sandholm; Sanna S Virtanen; Michelle Prudhomme; Fabrice Anizon; Pascale Moreau; Päivi J Koskinen
Journal:  Mol Cancer       Date:  2010-10-19       Impact factor: 27.401

8.  Bcl2 family proteins in carcinogenesis and the treatment of cancer.

Authors:  Anna Frenzel; Francesca Grespi; Waldemar Chmelewskij; Andreas Villunger
Journal:  Apoptosis       Date:  2009-04       Impact factor: 4.677

9.  Pim-1 kinase phosphorylates RUNX family transcription factors and enhances their activity.

Authors:  Teija L T Aho; Jouko Sandholm; Katriina J Peltola; Yoshiaki Ito; Päivi J Koskinen
Journal:  BMC Cell Biol       Date:  2006-05-09       Impact factor: 4.241

10.  Cryptic promoter activity in the DNA sequence corresponding to the pim-1 5'-UTR.

Authors:  Zeping Wang; Matt Weaver; Nancy S Magnuson
Journal:  Nucleic Acids Res       Date:  2005-04-20       Impact factor: 16.971
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.